Lmr Partners LLP Astrazeneca PLC Transaction History
Lmr Partners LLP
- $10.5 Billion
- Q2 2025
A detailed history of Lmr Partners LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Lmr Partners LLP holds 22,895 shares of AZN stock, worth $1.91 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,895
Previous 188,200
87.83%
Holding current value
$1.91 Million
Previous $13.8 Million
88.44%
% of portfolio
0.02%
Previous 0.17%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,433Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.32 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.43 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.86 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.61 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.59 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $258B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...